Evaluating breast cancer risk projections for Hispanic women

Breast Cancer Research and Treatment

Volumn 132, Issue 1, 2012, Pages 347-353

  Banegas, Matthew P ^a,b   Gail, Mitchell H ^c   LaCroix, Andrea ^b   Thompson, Beti ^a,b   Martinez, Maria Elena ^d   Wactawski Wende, Jean ^e   John, Esther M ^f,g   Hubbell, F Allan ^h   Yasmeen, Shagufta ⁱ   Katki, Hormuzd A ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^g STANFORD CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BCRAT; Breast cancer; Hispanic; Risk assessment; Risk prediction

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CANCER RISK ASSESSMENT TOOL; CALIBRATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ETHNIC DIFFERENCE; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL AGE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

AREA UNDER CURVE; BREAST NEOPLASMS; CALIBRATION; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, BIOLOGICAL; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84857912892     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1900-9     Document Type: Article

References (28)

1. American Cancer Society (ACS) (2007) Breast Cancer Facts & Figures 2007-2008. ACS, Atlanta
2. O'Brien K, Cokkinides V, Jemal A, Cardinez CJ, Murray T, Samuels A, Ward E, Thun MJ (2003) Cancer statistics for Hispanics, 2003. CA Cancer J Clin 53(4):208-226 (Pubitemid 37045790)
3. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879-1886 (Pubitemid 20026073)
4. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439-448
5. Bondy ML, Spitz MR, Halabi S, Fueger JJ, Vogel VG (1992) Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control 3(4):377-382
6. Hines LM, Risendal B, Slattery ML, Baumgartner KB, Giuliano AR, Sweeney C, Rollison DE, Byers T (2010) Comparative analysis of breast cancer risk factors among Hispanic and non- Hispanic white women. Cancer 116(13):3215-3223
7. Risendal B, Hines LM, Sweeney C, Slattery ML, Giuliano AR, Baumgartner KB, Curtin K, Byers TE (2008) Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women. Cancer Causes Control 19(10):1349-1355
8. Sweeney C, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Murtaugh MA, Slattery ML (2008) Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control 19(4):391-401
9. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG (1994) Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86(8):620-625 (Pubitemid 24143172)
10. Spiegelman D, Colditz GA, Hunter D, Hertzmark E (1994) Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 86(8):600-607
11. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93(5):358-366
12. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91(18):1541-1548 (Pubitemid 29457958)
13. Gail MH, Pfeiffer RM (2005) On criteria for evaluating models of absolute risk. Biostatistics 6(2):227-239 (Pubitemid 41240355)
14. Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K et al (2009) American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 27(19):3235-3258
15. Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103(18):1397-1402
16. Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV Jr, Park Y, Schatzkin A, Visvanathan K, Pfeiffer RM (2010) Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 28(14):2411-2417
17. Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA (2007) Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 99(22):1695-1705 (Pubitemid 351767220)
18. Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels- Tinker L, Howard B, Ockene J (2003) The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol 13(9 Suppl):S87-S97 (Pubitemid 37324178)
19. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE (2003) The Women's Health Initiative recruitment methods and results. Ann Epidemiol 13(9 Suppl):S18-S77 (Pubitemid 37324176)
20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group (1998) Control Clin Trials 19(1):61-109
21. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M et al (2003) Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13(9 Suppl):S122-S128 (Pubitemid 37324181)
22. Wieand S, Gail MH, James BR, James KL (1989) A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data. Biometrika 76(3):585-592
23. John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14(12):2905-2913 (Pubitemid 43068823)
24. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL (2010) Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol 173(2):201-216
25. Miranda PY, Wilkinson AV, Etzel CJ, Zhou R, Jones LA, Thompson P, Bondy ML (2011) Policy implications of early onset breast cancer among Mexican-origin women. Cancer 117(2):390-397
26. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71(5):800-809 (Pubitemid 27237202)
27. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389-1399
28. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P et al (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362(11):986-993